nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—DRD3—Parkinson's disease	0.214	0.283	CbGaD
Yohimbine—HTR1A—Parkinson's disease	0.175	0.231	CbGaD
Yohimbine—DRD2—Parkinson's disease	0.148	0.196	CbGaD
Yohimbine—HTR2A—Parkinson's disease	0.115	0.151	CbGaD
Yohimbine—CYP2D6—Parkinson's disease	0.105	0.138	CbGaD
Yohimbine—DRD3—telencephalic ventricle—Parkinson's disease	0.00447	0.0514	CbGeAlD
Yohimbine—HTR2A—enteric nervous system—Parkinson's disease	0.00398	0.0458	CbGeAlD
Yohimbine—Deserpidine—SLC18A2—Parkinson's disease	0.00368	0.442	CrCbGaD
Yohimbine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00302	0.0347	CbGeAlD
Yohimbine—Rescinnamine—SLC18A2—Parkinson's disease	0.00279	0.335	CrCbGaD
Yohimbine—HTR2A—locus ceruleus—Parkinson's disease	0.00263	0.0302	CbGeAlD
Yohimbine—HTR1B—telencephalic ventricle—Parkinson's disease	0.00259	0.0298	CbGeAlD
Yohimbine—HTR1D—telencephalic ventricle—Parkinson's disease	0.00251	0.0289	CbGeAlD
Yohimbine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00249	0.0286	CbGeAlD
Yohimbine—HTR2A—cerebellar cortex—Parkinson's disease	0.00214	0.0246	CbGeAlD
Yohimbine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00209	0.0241	CbGeAlD
Yohimbine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00208	0.0239	CbGeAlD
Yohimbine—DRD2—telencephalic ventricle—Parkinson's disease	0.00189	0.0217	CbGeAlD
Yohimbine—HTR1F—forebrain—Parkinson's disease	0.00165	0.019	CbGeAlD
Yohimbine—Reserpine—SLC18A2—Parkinson's disease	0.0016	0.193	CrCbGaD
Yohimbine—HTR2A—pons—Parkinson's disease	0.00152	0.0174	CbGeAlD
Yohimbine—HTR2A—autonomic nervous system—Parkinson's disease	0.0014	0.0161	CbGeAlD
Yohimbine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00125	0.0143	CbGeAlD
Yohimbine—DRD2—nerve—Parkinson's disease	0.00119	0.0137	CbGeAlD
Yohimbine—ADRA2A—peripheral nervous system—Parkinson's disease	0.00119	0.0136	CbGeAlD
Yohimbine—SLC6A4—hindbrain—Parkinson's disease	0.00111	0.0128	CbGeAlD
Yohimbine—HTR2A—peripheral nervous system—Parkinson's disease	0.00101	0.0116	CbGeAlD
Yohimbine—HTR1A—hindbrain—Parkinson's disease	0.000988	0.0114	CbGeAlD
Yohimbine—HTR1F—head—Parkinson's disease	0.000946	0.0109	CbGeAlD
Yohimbine—HTR1F—nervous system—Parkinson's disease	0.000897	0.0103	CbGeAlD
Yohimbine—DRD2—hindbrain—Parkinson's disease	0.000893	0.0103	CbGeAlD
Yohimbine—ADRA1D—forebrain—Parkinson's disease	0.000877	0.0101	CbGeAlD
Yohimbine—HTR1F—central nervous system—Parkinson's disease	0.000864	0.00993	CbGeAlD
Yohimbine—HTR2A—nerve—Parkinson's disease	0.000786	0.00904	CbGeAlD
Yohimbine—HTR1B—brainstem—Parkinson's disease	0.000702	0.00807	CbGeAlD
Yohimbine—HTR1F—brain—Parkinson's disease	0.000686	0.00788	CbGeAlD
Yohimbine—HTR1D—brainstem—Parkinson's disease	0.000679	0.00781	CbGeAlD
Yohimbine—HTR1B—forebrain—Parkinson's disease	0.000677	0.00778	CbGeAlD
Yohimbine—HTR2C—brainstem—Parkinson's disease	0.000673	0.00773	CbGeAlD
Yohimbine—DRD3—head—Parkinson's disease	0.000668	0.00768	CbGeAlD
Yohimbine—HTR1D—forebrain—Parkinson's disease	0.000656	0.00754	CbGeAlD
Yohimbine—HTR2C—forebrain—Parkinson's disease	0.000649	0.00746	CbGeAlD
Yohimbine—SLC6A4—brainstem—Parkinson's disease	0.000638	0.00733	CbGeAlD
Yohimbine—DRD3—nervous system—Parkinson's disease	0.000634	0.00728	CbGeAlD
Yohimbine—SLC6A4—forebrain—Parkinson's disease	0.000615	0.00708	CbGeAlD
Yohimbine—DRD3—central nervous system—Parkinson's disease	0.00061	0.00701	CbGeAlD
Yohimbine—HTR2B—forebrain—Parkinson's disease	0.00061	0.00701	CbGeAlD
Yohimbine—HTR2A—hindbrain—Parkinson's disease	0.000589	0.00677	CbGeAlD
Yohimbine—HTR1B—cardiovascular system—Parkinson's disease	0.000573	0.00658	CbGeAlD
Yohimbine—HTR1A—brainstem—Parkinson's disease	0.000566	0.00651	CbGeAlD
Yohimbine—HTR1D—cardiovascular system—Parkinson's disease	0.000554	0.00637	CbGeAlD
Yohimbine—HTR1A—forebrain—Parkinson's disease	0.000546	0.00628	CbGeAlD
Yohimbine—CYP2D6—hindbrain—Parkinson's disease	0.000536	0.00617	CbGeAlD
Yohimbine—HTR2B—cardiovascular system—Parkinson's disease	0.000516	0.00593	CbGeAlD
Yohimbine—ADRA1B—head—Parkinson's disease	0.000513	0.0059	CbGeAlD
Yohimbine—DRD2—brainstem—Parkinson's disease	0.000512	0.00588	CbGeAlD
Yohimbine—ADRA1D—head—Parkinson's disease	0.000502	0.00577	CbGeAlD
Yohimbine—DRD2—forebrain—Parkinson's disease	0.000494	0.00568	CbGeAlD
Yohimbine—ADRA1B—nervous system—Parkinson's disease	0.000487	0.0056	CbGeAlD
Yohimbine—DRD3—brain—Parkinson's disease	0.000484	0.00557	CbGeAlD
Yohimbine—ADRA1D—nervous system—Parkinson's disease	0.000476	0.00547	CbGeAlD
Yohimbine—HTR2C—medulla oblongata—Parkinson's disease	0.000469	0.00539	CbGeAlD
Yohimbine—ADRA1B—central nervous system—Parkinson's disease	0.000469	0.00539	CbGeAlD
Yohimbine—HTR1A—cardiovascular system—Parkinson's disease	0.000462	0.00531	CbGeAlD
Yohimbine—ADRA1D—central nervous system—Parkinson's disease	0.000458	0.00527	CbGeAlD
Yohimbine—HTR1B—midbrain—Parkinson's disease	0.000447	0.00514	CbGeAlD
Yohimbine—HTR1B—spinal cord—Parkinson's disease	0.000436	0.00502	CbGeAlD
Yohimbine—HTR1D—midbrain—Parkinson's disease	0.000433	0.00498	CbGeAlD
Yohimbine—HTR2C—midbrain—Parkinson's disease	0.000429	0.00493	CbGeAlD
Yohimbine—HTR2C—spinal cord—Parkinson's disease	0.000418	0.00481	CbGeAlD
Yohimbine—SLC6A4—midbrain—Parkinson's disease	0.000406	0.00467	CbGeAlD
Yohimbine—SLC6A4—spinal cord—Parkinson's disease	0.000397	0.00456	CbGeAlD
Yohimbine—HTR1B—head—Parkinson's disease	0.000388	0.00446	CbGeAlD
Yohimbine—ADRA2A—forebrain—Parkinson's disease	0.000383	0.0044	CbGeAlD
Yohimbine—HTR1D—head—Parkinson's disease	0.000375	0.00432	CbGeAlD
Yohimbine—ADRA1B—brain—Parkinson's disease	0.000372	0.00428	CbGeAlD
Yohimbine—HTR2C—head—Parkinson's disease	0.000372	0.00427	CbGeAlD
Yohimbine—HTR2A—embryo—Parkinson's disease	0.000368	0.00423	CbGeAlD
Yohimbine—HTR1B—nervous system—Parkinson's disease	0.000368	0.00423	CbGeAlD
Yohimbine—ADRA1D—brain—Parkinson's disease	0.000364	0.00418	CbGeAlD
Yohimbine—HTR1A—midbrain—Parkinson's disease	0.000361	0.00415	CbGeAlD
Yohimbine—HTR1D—nervous system—Parkinson's disease	0.000356	0.00409	CbGeAlD
Yohimbine—HTR1B—central nervous system—Parkinson's disease	0.000354	0.00407	CbGeAlD
Yohimbine—HTR2C—nervous system—Parkinson's disease	0.000352	0.00405	CbGeAlD
Yohimbine—SLC6A4—head—Parkinson's disease	0.000352	0.00405	CbGeAlD
Yohimbine—HTR1A—spinal cord—Parkinson's disease	0.000352	0.00405	CbGeAlD
Yohimbine—HTR2B—head—Parkinson's disease	0.000349	0.00401	CbGeAlD
Yohimbine—ADRA2C—medulla oblongata—Parkinson's disease	0.000347	0.00399	CbGeAlD
Yohimbine—HTR1D—central nervous system—Parkinson's disease	0.000343	0.00394	CbGeAlD
Yohimbine—HTR2C—central nervous system—Parkinson's disease	0.000339	0.0039	CbGeAlD
Yohimbine—HTR2A—brainstem—Parkinson's disease	0.000337	0.00388	CbGeAlD
Yohimbine—SLC6A4—nervous system—Parkinson's disease	0.000334	0.00384	CbGeAlD
Yohimbine—HTR2B—nervous system—Parkinson's disease	0.000331	0.00381	CbGeAlD
Yohimbine—DRD2—midbrain—Parkinson's disease	0.000326	0.00375	CbGeAlD
Yohimbine—HTR2A—forebrain—Parkinson's disease	0.000326	0.00374	CbGeAlD
Yohimbine—SLC6A4—central nervous system—Parkinson's disease	0.000322	0.0037	CbGeAlD
Yohimbine—HTR2B—central nervous system—Parkinson's disease	0.000319	0.00366	CbGeAlD
Yohimbine—ADRA2C—midbrain—Parkinson's disease	0.000317	0.00364	CbGeAlD
Yohimbine—HTR1A—head—Parkinson's disease	0.000313	0.0036	CbGeAlD
Yohimbine—ADRA2C—spinal cord—Parkinson's disease	0.000309	0.00356	CbGeAlD
Yohimbine—CYP2D6—brainstem—Parkinson's disease	0.000307	0.00353	CbGeAlD
Yohimbine—CYP2D6—forebrain—Parkinson's disease	0.000297	0.00341	CbGeAlD
Yohimbine—HTR1A—nervous system—Parkinson's disease	0.000297	0.00341	CbGeAlD
Yohimbine—HTR1A—central nervous system—Parkinson's disease	0.000286	0.00328	CbGeAlD
Yohimbine—DRD2—head—Parkinson's disease	0.000283	0.00325	CbGeAlD
Yohimbine—HTR1B—brain—Parkinson's disease	0.000281	0.00323	CbGeAlD
Yohimbine—HTR1A—cerebellum—Parkinson's disease	0.000279	0.00321	CbGeAlD
Yohimbine—ADRA2A—medulla oblongata—Parkinson's disease	0.000277	0.00318	CbGeAlD
Yohimbine—HTR2A—cardiovascular system—Parkinson's disease	0.000275	0.00317	CbGeAlD
Yohimbine—ADRA2C—head—Parkinson's disease	0.000275	0.00316	CbGeAlD
Yohimbine—HTR1D—brain—Parkinson's disease	0.000272	0.00313	CbGeAlD
Yohimbine—HTR2C—brain—Parkinson's disease	0.000269	0.0031	CbGeAlD
Yohimbine—DRD2—nervous system—Parkinson's disease	0.000268	0.00308	CbGeAlD
Yohimbine—ADRA2C—nervous system—Parkinson's disease	0.000261	0.003	CbGeAlD
Yohimbine—DRD2—central nervous system—Parkinson's disease	0.000258	0.00297	CbGeAlD
Yohimbine—SLC6A4—brain—Parkinson's disease	0.000255	0.00294	CbGeAlD
Yohimbine—HTR2B—brain—Parkinson's disease	0.000253	0.00291	CbGeAlD
Yohimbine—ADRA2A—midbrain—Parkinson's disease	0.000253	0.00291	CbGeAlD
Yohimbine—DRD2—cerebellum—Parkinson's disease	0.000252	0.0029	CbGeAlD
Yohimbine—ADRA2C—central nervous system—Parkinson's disease	0.000251	0.00288	CbGeAlD
Yohimbine—Reserpine—ABCB1—Parkinson's disease	0.000249	0.03	CrCbGaD
Yohimbine—ADRA2A—spinal cord—Parkinson's disease	0.000247	0.00284	CbGeAlD
Yohimbine—ADRA2C—cerebellum—Parkinson's disease	0.000245	0.00282	CbGeAlD
Yohimbine—HTR2A—medulla oblongata—Parkinson's disease	0.000235	0.0027	CbGeAlD
Yohimbine—HTR1A—brain—Parkinson's disease	0.000227	0.00261	CbGeAlD
Yohimbine—ADRA2A—head—Parkinson's disease	0.000219	0.00252	CbGeAlD
Yohimbine—HTR2A—midbrain—Parkinson's disease	0.000215	0.00247	CbGeAlD
Yohimbine—HTR2A—spinal cord—Parkinson's disease	0.00021	0.00241	CbGeAlD
Yohimbine—ADRA2A—nervous system—Parkinson's disease	0.000208	0.00239	CbGeAlD
Yohimbine—DRD2—brain—Parkinson's disease	0.000205	0.00236	CbGeAlD
Yohimbine—ADRA2A—central nervous system—Parkinson's disease	0.0002	0.0023	CbGeAlD
Yohimbine—ADRA2C—brain—Parkinson's disease	0.000199	0.00229	CbGeAlD
Yohimbine—ADRA2A—cerebellum—Parkinson's disease	0.000196	0.00225	CbGeAlD
Yohimbine—HTR2A—head—Parkinson's disease	0.000186	0.00214	CbGeAlD
Yohimbine—HTR2A—nervous system—Parkinson's disease	0.000177	0.00203	CbGeAlD
Yohimbine—HTR2A—central nervous system—Parkinson's disease	0.00017	0.00196	CbGeAlD
Yohimbine—CYP2D6—head—Parkinson's disease	0.00017	0.00195	CbGeAlD
Yohimbine—HTR2A—cerebellum—Parkinson's disease	0.000166	0.00191	CbGeAlD
Yohimbine—CYP3A4—nervous system—Parkinson's disease	0.000164	0.00188	CbGeAlD
Yohimbine—CYP2D6—nervous system—Parkinson's disease	0.000161	0.00185	CbGeAlD
Yohimbine—ADRA2A—brain—Parkinson's disease	0.000159	0.00183	CbGeAlD
Yohimbine—CYP3A4—central nervous system—Parkinson's disease	0.000158	0.00181	CbGeAlD
Yohimbine—CYP2D6—central nervous system—Parkinson's disease	0.000155	0.00178	CbGeAlD
Yohimbine—CYP2D6—cerebellum—Parkinson's disease	0.000152	0.00174	CbGeAlD
Yohimbine—HTR2A—brain—Parkinson's disease	0.000135	0.00155	CbGeAlD
Yohimbine—CYP2D6—brain—Parkinson's disease	0.000123	0.00142	CbGeAlD
Yohimbine—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	9.73e-06	6.56e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	9.66e-06	6.51e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CTGF—Parkinson's disease	9.64e-06	6.49e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	9.63e-06	6.49e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	9.61e-06	6.48e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—FGB—Parkinson's disease	9.54e-06	6.43e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	9.52e-06	6.42e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	9.49e-06	6.4e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	9.48e-06	6.39e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	9.48e-06	6.39e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	9.45e-06	6.37e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	9.45e-06	6.37e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	9.4e-06	6.33e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	9.39e-06	6.33e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	9.39e-06	6.33e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	9.35e-06	6.3e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	9.34e-06	6.3e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	9.2e-06	6.2e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	9.17e-06	6.18e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—COMT—Parkinson's disease	9.16e-06	6.17e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	9.15e-06	6.16e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	9.15e-06	6.16e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	9.14e-06	6.16e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	9.14e-06	6.16e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—GSTP1—Parkinson's disease	9.12e-06	6.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—FBP1—Parkinson's disease	9.11e-06	6.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—DBH—Parkinson's disease	9.11e-06	6.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GBA—Parkinson's disease	9.11e-06	6.14e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	9.1e-06	6.13e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	9.1e-06	6.13e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—MAOA—Parkinson's disease	9.1e-06	6.13e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	9.04e-06	6.09e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	9.03e-06	6.09e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—NGF—Parkinson's disease	9.02e-06	6.08e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	9.02e-06	6.08e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	9e-06	6.06e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—HMOX1—Parkinson's disease	8.99e-06	6.06e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	8.98e-06	6.05e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	8.88e-06	5.99e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—NQO1—Parkinson's disease	8.88e-06	5.98e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	8.85e-06	5.97e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	8.85e-06	5.97e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—NGF—Parkinson's disease	8.83e-06	5.95e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IGF2—Parkinson's disease	8.8e-06	5.93e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	8.8e-06	5.93e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—TH—Parkinson's disease	8.75e-06	5.9e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	8.74e-06	5.89e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	8.71e-06	5.87e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	8.71e-06	5.87e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	8.7e-06	5.86e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—ABCB1—Parkinson's disease	8.63e-06	5.82e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—MAOB—Parkinson's disease	8.61e-06	5.8e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	8.59e-06	5.79e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	8.54e-06	5.76e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	8.52e-06	5.74e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	8.5e-06	5.73e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	8.5e-06	5.73e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	8.5e-06	5.73e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	8.41e-06	5.67e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EDN1—Parkinson's disease	8.4e-06	5.66e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	8.4e-06	5.66e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CYCS—Parkinson's disease	8.4e-06	5.66e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—GSTM1—Parkinson's disease	8.38e-06	5.65e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	8.37e-06	5.64e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—NGF—Parkinson's disease	8.3e-06	5.59e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	8.29e-06	5.59e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	8.21e-06	5.53e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	8.16e-06	5.5e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	8.03e-06	5.41e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—GPX1—Parkinson's disease	8.02e-06	5.41e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—APOE—Parkinson's disease	7.99e-06	5.38e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	7.95e-06	5.36e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	7.94e-06	5.35e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	7.94e-06	5.35e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	7.9e-06	5.33e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	7.9e-06	5.33e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	7.9e-06	5.32e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	7.89e-06	5.32e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—APOE—Parkinson's disease	7.82e-06	5.27e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—NGF—Parkinson's disease	7.72e-06	5.2e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	7.72e-06	5.2e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	7.68e-06	5.17e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	7.67e-06	5.17e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	7.63e-06	5.14e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	7.59e-06	5.11e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—COMT—Parkinson's disease	7.44e-06	5.01e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	7.42e-06	5e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	7.42e-06	5e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	7.41e-06	4.99e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	7.4e-06	4.99e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—MTHFR—Parkinson's disease	7.4e-06	4.99e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—MAOA—Parkinson's disease	7.39e-06	4.98e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	7.37e-06	4.97e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	7.35e-06	4.95e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	7.35e-06	4.95e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	7.35e-06	4.95e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	7.32e-06	4.94e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	7.3e-06	4.92e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	7.3e-06	4.92e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	7.3e-06	4.92e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	7.29e-06	4.91e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	7.19e-06	4.85e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	7.19e-06	4.85e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	7.17e-06	4.83e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	7.09e-06	4.78e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	7.06e-06	4.76e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	7.01e-06	4.72e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	6.97e-06	4.7e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	6.97e-06	4.7e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—APOE—Parkinson's disease	6.89e-06	4.65e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—APOE—Parkinson's disease	6.83e-06	4.61e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	6.83e-06	4.61e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—INS—Parkinson's disease	6.82e-06	4.6e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	6.8e-06	4.59e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	6.73e-06	4.54e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	6.73e-06	4.54e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	6.7e-06	4.51e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—DDC—Parkinson's disease	6.69e-06	4.51e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—INS—Parkinson's disease	6.68e-06	4.5e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	6.64e-06	4.47e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	6.62e-06	4.46e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—GPX1—Parkinson's disease	6.52e-06	4.39e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	6.51e-06	4.39e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	6.51e-06	4.39e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	6.43e-06	4.33e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	6.41e-06	4.32e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	6.41e-06	4.32e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	6.4e-06	4.32e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	6.37e-06	4.3e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	6.33e-06	4.26e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.31e-06	4.25e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CTGF—Parkinson's disease	6.28e-06	4.23e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—INS—Parkinson's disease	6.27e-06	4.23e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	6.2e-06	4.18e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	6.17e-06	4.16e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	6.1e-06	4.11e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	6.03e-06	4.06e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	6.01e-06	4.05e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.96e-06	4.01e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5.93e-06	3.99e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.91e-06	3.98e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—INS—Parkinson's disease	5.89e-06	3.97e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.85e-06	3.94e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—INS—Parkinson's disease	5.84e-06	3.93e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—INS—Parkinson's disease	5.84e-06	3.93e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	5.83e-06	3.93e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.81e-06	3.92e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.79e-06	3.9e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	5.76e-06	3.88e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	5.76e-06	3.88e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—TH—Parkinson's disease	5.7e-06	3.84e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.68e-06	3.83e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	5.67e-06	3.82e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.63e-06	3.79e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	5.63e-06	3.79e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—APOE—Parkinson's disease	5.6e-06	3.77e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CYCS—Parkinson's disease	5.47e-06	3.69e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	5.29e-06	3.56e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—INS—Parkinson's disease	5.27e-06	3.55e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APOE—Parkinson's disease	5.23e-06	3.52e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	5.15e-06	3.47e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—INS—Parkinson's disease	5.09e-06	3.43e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	5.08e-06	3.42e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—INS—Parkinson's disease	5.06e-06	3.41e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	5.05e-06	3.4e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	5.04e-06	3.39e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	4.97e-06	3.35e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	4.94e-06	3.33e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—INS—Parkinson's disease	4.92e-06	3.32e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—COMT—Parkinson's disease	4.85e-06	3.27e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.85e-06	3.27e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.83e-06	3.25e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.81e-06	3.24e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—INS—Parkinson's disease	4.78e-06	3.22e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.76e-06	3.21e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	4.68e-06	3.15e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	4.67e-06	3.15e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	4.67e-06	3.15e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—IL6—Parkinson's disease	4.66e-06	3.14e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	4.64e-06	3.13e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	4.57e-06	3.08e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.57e-06	3.08e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—INS—Parkinson's disease	4.47e-06	3.01e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.43e-06	2.99e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—INS—Parkinson's disease	4.4e-06	2.96e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CASP3—Parkinson's disease	4.35e-06	2.93e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	4.35e-06	2.93e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—IL6—Parkinson's disease	4.32e-06	2.91e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	4.32e-06	2.91e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	4.29e-06	2.89e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GPX1—Parkinson's disease	4.25e-06	2.86e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.18e-06	2.82e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.11e-06	2.77e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	4e-06	2.7e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	4e-06	2.69e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	4e-06	2.69e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.92e-06	2.64e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.92e-06	2.64e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.9e-06	2.63e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.83e-06	2.58e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.79e-06	2.55e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.78e-06	2.55e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.77e-06	2.54e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.76e-06	2.54e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.74e-06	2.52e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—TH—Parkinson's disease	3.73e-06	2.51e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	3.67e-06	2.47e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—APOE—Parkinson's disease	3.65e-06	2.46e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	3.64e-06	2.45e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.61e-06	2.43e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.61e-06	2.43e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.58e-06	2.42e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.58e-06	2.41e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3.48e-06	2.35e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.46e-06	2.33e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-06	2.27e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.33e-06	2.24e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	3.32e-06	2.23e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.3e-06	2.23e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.27e-06	2.21e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.25e-06	2.19e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—COMT—Parkinson's disease	3.17e-06	2.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.15e-06	2.13e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.15e-06	2.12e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—INS—Parkinson's disease	3.12e-06	2.1e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.11e-06	2.1e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	3.06e-06	2.06e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.01e-06	2.03e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.99e-06	2.01e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.98e-06	2.01e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.98e-06	2.01e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.96e-06	1.99e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL6—Parkinson's disease	2.92e-06	1.97e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.9e-06	1.95e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.78e-06	1.87e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	2.74e-06	1.85e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.74e-06	1.84e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.56e-06	1.73e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.55e-06	1.72e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL6—Parkinson's disease	2.55e-06	1.72e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—APOE—Parkinson's disease	2.39e-06	1.61e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	2.3e-06	1.55e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.22e-06	1.5e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.21e-06	1.49e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	2.15e-06	1.45e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	2.12e-06	1.43e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—INS—Parkinson's disease	2.04e-06	1.37e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.95e-06	1.32e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.29e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.75e-06	1.18e-05	CbGpPWpGaD
